Ask Warren

ViGenCell

308080 · KOSDAQ · ₩308080 · 바이젠셀

₩4,655▼ ₩215 (4.41%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

20252024202320222021
Revenue₩23M₩279M₩0₩0₩0
Cost of sales₩12M₩267M₩0₩0₩0
Gross profit₩11M₩12M₩0₩0₩0
Operating income−₩17B−₩15B−₩20B−₩18B−₩13B
Net income−₩16B−₩14B−₩18B−₩17B−₩11B
Net income to shareholders−₩16B−₩14B−₩18B−₩17B−₩11B

Balance sheet

20252024202320222021
Total assets₩54B₩67B₩81B₩99B₩117B
Current assets₩34B₩46B₩54B₩70B₩67B
Cash and equivalents₩3.9B₩11B₩18B₩8.3B₩32B
Total liabilities₩11B₩9.3B₩9.6B₩9.7B₩12B
Current liabilities₩1.7B₩8B₩8.5B₩8.4B₩10B
Borrowings₩7.4B₩7.4B₩7.4B₩7.4B₩9B
Total equity₩44B₩58B₩71B₩90B₩105B
Shareholders' equity₩44B₩58B₩71B₩90B₩105B

Cash flow

20252024202320222021
Cash from operations−₩14B−₩11B−₩15B−₩11B−₩8B
Capital spending₩729M————
Free cash flow−₩15B−₩11B−₩15B−₩11B−₩8B

Consolidated where available. Amounts in won.

Also known as: ViGenCell / 바이젠셀 / 308080 / KRX:308080

Source: KRX statistical information